PODD - INSULET CORP

242.89
1.050   0.432%

Share volume: 964,067
Last Updated: 03-04-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.01%

PREVIOUS CLOSE
CHG
CHG%
$241.84
1.05
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
29%
Profitability 0%
Dept financing 50%
Liquidity 75%
Performance 42%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-1.04%
1 Month
-0.11%
3 Months
-20.23%
6 Months
-30.29%
1 Year
-10.31%
2 Year
48.17%
Key data
Stock price
$242.89
P/E Ratio 
80.92
DAY RANGE
$238.00 - $247.60
EPS 
$3.51
52 WEEK RANGE
$230.05 - $354.88
52 WEEK CHANGE
-$6.46
MARKET CAP 
19.995 B
YIELD 
N/A
SHARES OUTSTANDING 
70.396 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
08-07-2025
BETA 
0.95
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$1,111,791
AVERAGE 30 VOLUME 
$1,146,911
Company detail
CEO: James R. Hollingshead
Region: US
Website: insulet.com
Employees: 2,600
IPO year: 2007
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless device that is worn on the body for up to three days at a time. The company sells its products primarily through independent distributors and pharmacy channels.

Recent news